Meredith McMorrow
Impact in
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Epidemiology top 1%
- Respiratory viral infections research
- Influenza Virus Research Studies
- Pneumonia and Respiratory Infections
Papers in
- Epidemiology 106
- Respiratory viral infections research 55
- Influenza Virus Research Studies 43
- Pneumonia and Respiratory Infections 12
-
- SARS-CoV-2 and COVID-19 Research 35
- COVID-19 Clinical Research Studies 9
- Co-authors
- S. Patrick Kachur (8 shared papers)Mila M. Prill (6 shared papers)Jefferson Michael Jones (6 shared papers)Cheryl Cohen (45 shared papers)Stefano Tempia (43 shared papers)Michael Aidoo (1 shared paper)Sibongile Walaza (33 shared papers)Adam L. Cohen (23 shared papers)
- Journals
- MMWR Morbidity and Mortality Weekly Report (24 papers)Clinical Infectious Diseases (14 papers)Influenza and Other Respiratory Viruses (13 papers)Open Forum Infectious Diseases (11 papers)Vaccine (9 papers)
- Partner nations
- United StatesSouth AfricaUganda
In The Last Decade
Meredith McMorrow
165 papers receiving 5.7k citations
Meredith McMorrow's Hit Papers
Peers
Comparison fields: 5 of 126
- Infectious Diseases 1.9k
- Epidemiology 2.6k
- Modeling and Simulation 255
- Health 415
- Public Health, Environmental and Occupational Health 634
Countries citing papers authored by Meredith McMorrow
This map shows the geographic impact of Meredith McMorrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meredith McMorrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meredith McMorrow more than expected).
Fields of papers citing papers by Meredith McMorrow
This network shows the impact of papers produced by Meredith McMorrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meredith McMorrow. The network helps show where Meredith McMorrow may publish in the future.
Co-authors
The 25 scholars most cited alongside Meredith McMorrow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 167 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 Hit paper breakdown → | 2023 | 251 |
| 2 | 2021 | 227 | |
| 3 | Seasonality of Respiratory Syncytial Virus — United States, 2017–2023 Hit paper breakdown → | 2023 | 223 |
| 4 | Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 Hit paper breakdown → | 2023 | 218 |
| 5 | 2021 | 187 | |
| 6 | 2011 | 161 | |
| 7 | Hospitalizations of Children and Adolescents with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, July 2021–January 2022 Hit paper breakdown → | 2022 | 158 |
| 8 | Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus–Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season — New Vaccine Surveillance Network, October 2023–February 2024 Hit paper breakdown → | 2024 | 153 |
| 9 | 2013 | 144 | |
| 10 | 2021 | 144 | |
| 11 | 2022 | 133 | |
| 12 | 2022 | 133 | |
| 13 | 2021 | 119 | |
| 14 | 2022 | 110 | |
| 15 | 2008 | 104 | |
| 16 | 2022 | 94 | |
| 17 | 2022 | 91 | |
| 18 | 2021 | 89 | |
| 19 | 2021 | 84 | |
| 20 | 2022 | 84 |
About Meredith McMorrow
Meredith McMorrow is a scholar working on Epidemiology, Infectious Diseases, Health, Public Health, Environmental and Occupational Health and Modeling and Simulation, having authored 167 papers that have together received 6k indexed citations. Recurring topics across this work include Respiratory viral infections research (55 papers), Influenza Virus Research Studies (43 papers), SARS-CoV-2 and COVID-19 Research (35 papers), Malaria Research and Control (13 papers), Pneumonia and Respiratory Infections (12 papers), COVID-19 Clinical Research Studies (9 papers), Vaccine Coverage and Hesitancy (7 papers) and COVID-19 epidemiological studies (5 papers). The work is most often cited by research in Infectious Diseases (1.9k citations), Epidemiology (2.6k citations), Modeling and Simulation (255 citations), Health (415 citations) and Public Health, Environmental and Occupational Health (634 citations). Meredith McMorrow has collaborated with scholars based in United States, South Africa and Uganda. Frequent co-authors include S. Patrick Kachur, Mila M. Prill, Jefferson Michael Jones, Cheryl Cohen, Stefano Tempia, Michael Aidoo, Sibongile Walaza, Adam L. Cohen, Katherine E. Fleming-Dutra and Irene M Masanja. Their work appears in journals such as MMWR Morbidity and Mortality Weekly Report, Clinical Infectious Diseases, Influenza and Other Respiratory Viruses, Open Forum Infectious Diseases and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.